To further investigate the in vivo role of RanBP1 in CD147-modulated paclitaxel response, we performed a xenograft assay in immunodeficient mice with cells from the ovarian cancer cell line SK-OV-3 overexpressing CD147 and/or shRNAs targeting RanBP1 (shRanBP1). Here, BSG is linked to ovarian cancer.